Authors
Sun Young Cho, Cheol-In Kang, Jungok Kim, Young Eun Ha, Doo Ryeon Chung, Nam Yong Lee, Kyong Ran Peck, Jae-Hoon Song
Publication date
2014/1
Journal
Antimicrobial agents and chemotherapy
Volume
58
Issue
1
Pages
581-583
Publisher
American Society for Microbiology
Description
A retrospective study was conducted to evaluate the efficacy of levofloxacin in the treatment of Stenotrophomonas maltophilia bacteremia. The 30-day mortality rates were similar between the trimerthoprim-sulfamethoxazole (TMP-SMX) and levofloxacin treatment groups. Adverse events related to antibiotics occurred more frequently in patients receiving TMP-SMX, and recurrent bacteremia due to levofloxacin-resistant S. maltophilia strains developed in patients treated with levofloxacin. Our data suggest that levofloxacin can be a useful alternative option for treating S. maltophilia infections.
Scholar articles
SY Cho, CI Kang, J Kim, YE Ha, DR Chung, NY Lee… - Antimicrobial agents and chemotherapy, 2014